Gupta Pankaj, Jain Vivek, Pareek Ashutosh, Kumari Preeti, Singh Randhir, Agarwal Priyanka, Sharma Veena
Department of Pharmacology, DDPR Central Research Institute for Homoeopathy, Noida, India.
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
J Tradit Complement Med. 2016 Nov 25;7(3):307-314. doi: 10.1016/j.jtcme.2016.11.001. eCollection 2017 Jul.
Rising popularity of phytomedicines in various diseased conditions have strengthened the significance of plant-research and evaluation of phytoextracts in clinical manifestations. a medicinal plant, known for its anti-oxidant and anti-diabetic activity is a rich source of phytochemicals with antihyperglycemic and antihyperlipidemic activities. However, its possible role in diabetic complications is not evaluated yet. The present study explores the possible role of alcoholic extract of heartwood of in the treatment of long-term diabetic complications. The alcoholic extract of was evaluated for advanced glycation-end-products formation, erythrocyte sorbitol accumulation and rat kidney aldose reductase enzyme inhibition at the concentration of 25-400 μg/ml using bioassays. Also the phytoextract at the concentration of 10-320 μg/ml was evaluated for its antioxidant potential by antioxidant assays which includes, determination of total phenol content; reducing power assay; nitric oxide scavenging activity; superoxide radical scavenging activity; total antioxidant capacity; total flavonoid content; DPPH scavenging activity; and hydrogen peroxide scavenging activity. The alcoholic extract of across varying concentrations showed inhibitory effect as evident by IC on advanced glycation-end-products formation (55.39 μg/ml), sorbitol accumulation (151.00 μg/ml) and rat kidney aldose reductase (195.88 μg/ml). The phytoextract also exhibited high phenolic and flavonoid contents with promising antioxidant potential against the antioxidant assays evaluated. The present investigation suggests that the phytoextract showed prominent antioxidant, antiglycation property and, inhibited accumulation of sorbitol and ALR enzyme, thus promising a beneficial role in reducing/delaying diabetic complications.
植物药在各种疾病状况下日益普及,这增强了植物研究以及对植物提取物在临床表现方面进行评估的重要性。一种以其抗氧化和抗糖尿病活性而闻名的药用植物,是具有降血糖和降血脂活性的植物化学物质的丰富来源。然而,其在糖尿病并发症中可能发挥的作用尚未得到评估。本研究探讨了该植物心材乙醇提取物在治疗长期糖尿病并发症中的可能作用。使用生物测定法,在25 - 400μg/ml的浓度下评估了该植物乙醇提取物对晚期糖基化终产物形成、红细胞山梨醇积累和大鼠肾脏醛糖还原酶的抑制作用。此外,通过抗氧化测定法,在10 - 320μg/ml的浓度下评估了该植物提取物的抗氧化潜力,这些测定法包括总酚含量的测定、还原能力测定、一氧化氮清除活性、超氧自由基清除活性、总抗氧化能力、总黄酮含量、DPPH清除活性和过氧化氢清除活性。不同浓度的该植物乙醇提取物均显示出抑制作用,通过IC值可明显看出其对晚期糖基化终产物形成(55.39μg/ml)、山梨醇积累(151.00μg/ml)和大鼠肾脏醛糖还原酶(195.88μg/ml)的抑制作用。该植物提取物还表现出高酚类和黄酮类含量,在评估的抗氧化测定中具有良好的抗氧化潜力。本研究表明,该植物提取物具有显著的抗氧化、抗糖化特性,并能抑制山梨醇和醛糖还原酶的积累,因此有望在减少/延缓糖尿病并发症方面发挥有益作用。